Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

DSpace Repository

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine

Author: Schlenk, R. F.; Weber, D.; Herr, W.; Wulf, G.; Salih, H. R.; Derigs, H. G.; Kuendgen, A.; Ringhoffer, M.; Hertenstein, B.; Martens, U. M.; Griesshammer, M.; Bernhard, H.; Krauter, J.; Girschikofsky, M.; Wolf, D.; Lange, E.; Westermann, J.; Koller, E.; Kremers, S.; Wattad, M.; Heuser, M.; Thol, F.; Goehring, G.; Haase, D.; Teleanu, V; Gaidzik, V; Benner, A.; Doehner, K.; Ganser, A.; Paschka, P.; Doehner, H.
Tübinger Autor(en):
Salih, Helmut Rainer
Published in: Leukemia (2019), Bd. 33, H. 8, S. 1923-1933
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/s41375-019-0395-y
ISSN: 1476-5551
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)